{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:08:49Z","timestamp":1779901729464,"version":"3.53.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,27]]},"DOI":"10.7759\/cureus.109753","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:01:26Z","timestamp":1779901286000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive Bulbar Weakness in an Older Male With Suspected Double-Seronegative Myasthenia Gravis Culminating in Myasthenic Crisis: A Case Report"],"prefix":"10.7759","author":[{"given":"Elina","family":"Kurkurina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinderjeet K","family":"Puar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahnavi","family":"Mundluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser L","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021, 10:2235. 10.3390\/jcm10112235","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2005.01137.x","article-title":"Seronegative myasthenia gravis: disease severity and prognosis","volume":"12","author":"Romi F","year":"2005","unstructured":"Romi F, Aarli JA, Gilhus NE. Seronegative myasthenia gravis: disease severity and prognosis. Eur J Neurol. 2005, 12:413-8. 10.1111\/j.1468-1331.2005.01137.x","journal-title":"Eur J Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13091286","article-title":"Diagnosis and management of seronegative myasthenia gravis: lights and shadows","volume":"13","author":"Vinciguerra C","year":"2023","unstructured":"Vinciguerra C, Bevilacqua L, Lupica A, et al.. Diagnosis and management of seronegative myasthenia gravis: lights and shadows. Brain Sci. 2023, 13:1286. 10.3390\/brainsci13091286","journal-title":"Brain Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26985","article-title":"Clinical features of LRP4\/agrin-antibody-positive myasthenia gravis: a multicenter study","volume":"62","author":"Rivner MH","year":"2020","unstructured":"Rivner MH, Quarles BM, Pan JX, et al.. Clinical features of LRP4\/agrin-antibody-positive myasthenia gravis: a multicenter study. Muscle Nerve. 2020, 62:333-43. 10.1002\/mus.26985","journal-title":"Muscle Nerve"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2032","article-title":"Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin","volume":"73","author":"Cort\u00e9s-Vicente E","year":"2016","unstructured":"Cort\u00e9s-Vicente E, Gallardo E, Mart\u00ednez M\u00c1, D\u00edaz-Manera J, Querol L, Rojas-Garc\u00eda R, Illa I. Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin. JAMA Neurol. 2016, 73:1099-104. 10.1001\/jamaneurol.2016.2032","journal-title":"JAMA Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.08.2570","article-title":"Investigation of the clinical features of double-seronegative myasthenia gravis","volume":"381","author":"Yutani S","year":"2017","unstructured":"Yutani S, Kawamura R, Netsu S, Mukai M, Nagata E, Takizawa S. Investigation of the clinical features of double-seronegative myasthenia gravis. J Neurol Sci. 2017, 381:914. 10.1016\/j.jns.2017.08.2570","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00604","article-title":"A practical approach to managing patients with myasthenia gravis-opinions and a review of the literature","volume":"11","author":"Farrugia ME","year":"2020","unstructured":"Farrugia ME, Goodfellow JA. A practical approach to managing patients with myasthenia gravis-opinions and a review of the literature. Front Neurol. 2020, 11:604. 10.3389\/fneur.2020.00604","journal-title":"Front Neurol"},{"key":"ref8","article-title":"Myasthenia gravis presenting as bulbar palsy","volume":"15","author":"Gosain D","year":"2023","unstructured":"Gosain D, Das T. Myasthenia gravis presenting as bulbar palsy. Cureus. 2023, 15:e46082.","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/2277-9175.151874","article-title":"Life-threatening misdiagnosis of bulbar onset myasthenia gravis as a motor neuron disease: how much can one rely on exaggerated deep tendon reflexes","volume":"4","author":"Basiri K","year":"2015","unstructured":"Basiri K, Ansari B, Okhovat AA. Life-threatening misdiagnosis of bulbar onset myasthenia gravis as a motor neuron disease: how much can one rely on exaggerated deep tendon reflexes. Adv Biomed Res. 2015, 4:58. 10.4103\/2277-9175.151874","journal-title":"Adv Biomed Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27832","article-title":"Myasthenic crisis","volume":"68","author":"Claytor B","year":"2023","unstructured":"Claytor B, Cho SM, Li Y. Myasthenic crisis. Muscle Nerve. 2023, 68:8-19. 10.1002\/mus.27832","journal-title":"Muscle Nerve"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2001.49136.x","article-title":"Myasthenia gravis: an elusive diagnosis in older people","volume":"49","author":"Ngeh JK","year":"2001","unstructured":"Ngeh JK, McElligott G. Myasthenia gravis: an elusive diagnosis in older people. J Am Geriatr Soc. 2001, 49:683-4. 10.1046\/j.1532-5415.2001.49136.x","journal-title":"J Am Geriatr Soc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880150616","article-title":"Diagnostic sensitivity of the laboratory tests in myasthenia gravis","volume":"15","author":"Oh SJ","year":"1992","unstructured":"Oh SJ, Kim DE, Kuruoglu R, Bradley RJ, Dwyer D. Diagnostic sensitivity of the laboratory tests in myasthenia gravis. Muscle Nerve. 1992, 15:720-4. 10.1002\/mus.880150616","journal-title":"Muscle Nerve"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4065\/73.11.1077","article-title":"Myasthenia gravis mimicking stroke in elderly patients","volume":"73","author":"Kleiner-Fisman G","year":"1998","unstructured":"Kleiner-Fisman G, Kott HS. Myasthenia gravis mimicking stroke in elderly patients. Mayo Clin Proc. 1998, 73:1077-8. 10.4065\/73.11.1077","journal-title":"Mayo Clin Proc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/982374","article-title":"Reference values for maximal inspiratory pressure: a systematic review","volume":"21","author":"Sclauser Pessoa IM","year":"2014","unstructured":"Sclauser Pessoa IM, Franco Parreira V, Fregonezi GA, Sheel AW, Chung F, Reid WD. Reference values for maximal inspiratory pressure: a systematic review. Can Respir J. 2014, 21:43-50. 10.1155\/2014\/982374","journal-title":"Can Respir J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2004.08.045","article-title":"Safety of succinylcholine in myasthenia gravis","volume":"45","author":"Levitan R","year":"2005","unstructured":"Levitan R. Safety of succinylcholine in myasthenia gravis. Ann Emerg Med. 2005, 45:225-6. 10.1016\/j.annemergmed.2004.08.045","journal-title":"Ann Emerg Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000421","article-title":"Greater number of plasma exchanges does not improve outcome in myasthenic crisis","volume":"24","author":"Hansen M","year":"2023","unstructured":"Hansen M, Neilson L, Parikh M, Katirji B. Greater number of plasma exchanges does not improve outcome in myasthenic crisis. J Clin Neuromuscul Dis. 2023, 24:199-206. 10.1097\/CND.0000000000000421","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.47795\/KXJY9725","article-title":"Myasthenia gravis and the elderly","volume":"23","author":"Ashraghi MR","year":"2024","unstructured":"Ashraghi MR, Leite MI. Myasthenia gravis and the elderly. Adv Clin Neurosci Rehabil. 2024, 23:10-3. 10.47795\/KXJY9725","journal-title":"Adv Clin Neurosci Rehabil"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/345905-progressive-bulbar-weakness-in-an-older-male-with-suspected-double-seronegative-myasthenia-gravis-culminating-in-myasthenic-crisis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:01:27Z","timestamp":1779901287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/345905-progressive-bulbar-weakness-in-an-older-male-with-suspected-double-seronegative-myasthenia-gravis-culminating-in-myasthenic-crisis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.109753","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}